Document is current
Any future updates will be listed below
-
Authors
Nevone, Alice
Girelli, Maria
Mangiacavalli, Silvia
Paiva, Bruno https://orcid.org/0000-0003-1977-3815
Milani, Paolo https://orcid.org/0000-0002-2268-9422
Cascino, Pasquale
Piscitelli, Maggie
Speranzini, Valentina https://orcid.org/0000-0002-7219-3097
Cartia, Claudio Salvatore https://orcid.org/0000-0002-0389-4164
Benvenuti, Pietro
Goicoechea, Ibai https://orcid.org/0000-0002-5329-2225
Fazio, Francesca
Basset, Marco https://orcid.org/0000-0003-3829-0499
Foli, Andrea
Nanci, Martina
Mazzini, Giulia
Caminito, Serena
Sesta, Melania Antonietta
Casarini, Simona https://orcid.org/0000-0003-4730-7467
Rognoni, Paola https://orcid.org/0000-0001-6350-1919
Lavatelli, Francesca
Petrucci, Maria Teresa
Olimpieri, Pier Paolo
Ricagno, Stefano
Arcaini, Luca https://orcid.org/0000-0002-9504-991X
Merlini, Giampaolo https://orcid.org/0000-0001-7680-3254
Palladini, Giovanni https://orcid.org/0000-0001-5994-5138
Nuvolone, Mario https://orcid.org/0000-0001-8334-1684
- License Information
-
More Information
Article History
Received: 23 February 2022
Revised: 5 May 2022
Accepted: 11 May 2022
First Online: 24 May 2022
Competing interests
: PC, GP, and MNu are inventors on a patent application related to immunoglobulin sequencing.
: Clinical records and biological samples were from subjects referred to the Italian Amyloid Center or to the Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy and to the University Hospital of Navarra, Pamplona, Spain for a diagnostic workout in the suspicion of systemic AL amyloidosis or MM. Per the Declaration of Helsinki, all patients gave their written informed consent for the use of their clinical data and biological samples for research purposes, and this study was approved by the local Institutional Review Board.
